Caption Management’s Cymabay Therapeutics CBAY Stock Holding History

Caption Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-30,000	Closed	-$108K	–	1937
2022 Q2	$88K	Buy	30,000 +20,000	+200%	+$47.8K	﹤0.01%	1303
2022 Q1	$31K	Buy	+10,000	New	+$31.5K	﹤0.01%	1384
2020 Q3	–	Sell	-89,900	Closed	-$314K	–	1319
2020 Q2	$314K	Buy	+89,900	New	+$259K	0.01%	747
2019 Q3	–	Sell	-30,000	Closed	-$215K	–	935
2019 Q2	$215K	Buy	+30,000	New	+$340K	0.01%	565

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caption Management's CBAY Position: Q3 2022 in Review

Caption Management sold out of Cymabay Therapeutics (CBAY) in Q3 2022, closing a stake of 30,000 shares — an estimated $108K sold.

Caption Management first reported a position in CBAY in Q2 2019 and held it in 4 quarters. The position peaked at $314K in Q2 2020. 100 funds tracked by Wall St. Rank hold CBAY as of Q3 2022.

Caption Management reported no remaining Cymabay Therapeutics position as of Q3 2022 after selling out during the quarter.
Caption Management sold 30,000 Cymabay Therapeutics shares in Q3 2022, an estimated $108K.
Caption Management first reported a position in Cymabay Therapeutics in Q2 2019 and held it in 4 quarters.
Caption Management's Cymabay Therapeutics position peaked at $314K in Q2 2020.
100 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q3 2022.

Based on Caption Management's 13F filing for Q3 2022, filed 14 Nov 2022.